CollPlant Biotechnologies Ltd. - Ordinary Shares (NQ:CLGN)

3.590 +0.130 (+3.76%)

Delayed Quote Updated: 12:27 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CollPlant Biotechnologies Ltd. - Ordinary Shares

< Previous 1 2 3 Next >

Williams Companies To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

May 28, 2025

Via Benzinga

Earnings Scheduled For May 28, 2025 ↗

May 28, 2025

Via Benzinga

Earnings Preview: CollPlant Biotechnologies ↗

May 27, 2025

Via Benzinga

CollPlant Biotechnologies's Earnings: A Preview ↗

November 26, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies ↗

August 21, 2024

Via Benzinga

Recap: CollPlant Biotechnologies Q3 Earnings ↗

November 29, 2023

Via Benzinga

Earnings Outlook For CollPlant Biotechnologies ↗

November 28, 2023

Via Benzinga

Earnings Scheduled For March 26, 2025 ↗

March 26, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 27, 2024

Via Benzinga

Earnings Scheduled For November 27, 2024 ↗

November 27, 2024

Via Benzinga

Preview: CollPlant Biotechnologies's Earnings ↗

August 23, 2023

Via Benzinga

CollPlant Biotechnologies: Q1 Earnings Insights ↗

May 24, 2023

Via Benzinga

Earnings Preview: CollPlant Biotechnologies ↗

May 23, 2023

Via Benzinga

Earnings Outlook For CollPlant Biotechnologies ↗

March 28, 2023

Via Benzinga

CLGN Stock Earnings: CollPlant Biotechnologies Beats EPS, Misses Revenue for Q2 2024 ↗

August 20, 2024

CLGN stock results show that CollPlant Biotechnologies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

CLGN Stock Earnings: CollPlant Biotechnologies Meets EPS, Misses Revenue for Q1 2024 ↗

May 29, 2024

CLGN stock results show that CollPlant Biotechnologies met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

CLGN Stock Earnings: CollPlant Biotechnologies Misses EPS, Misses Revenue for Q4 2023 ↗

April 04, 2024

CLGN stock results show that CollPlant Biotechnologies missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Earnings Scheduled For April 4, 2024 ↗

April 04, 2024

Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on revenue of $3.01 billion.

Via Benzinga

Earnings Scheduled For November 29, 2023 ↗

November 29, 2023

Companies Reporting Before The Bell • CollPlant Biotechnologies (NASDAQ:CLGN) is likely to report quarterly loss at $0.13 per share on revenue of $3.50 million.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 24, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 25, 2023

Via Benzinga

Why CollPlant Biotechnologies Stock Is Trading Higher ↗

June 26, 2023

CollPlant Biotechnologies Ltd (NASDAQ: CLGN) shares are trading higher Monday after the company announced it achieved a milestone in its product collaboration agreement with AbbVie Inc (NYSE:

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 26, 2023

Via Benzinga

Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 26, 2023

Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular...

Via Benzinga

Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs

April 04, 2023

From Stratasys Ltd.

Via Business Wire

Earnings Scheduled For May 24, 2023 ↗

May 24, 2023

Companies Reporting Before The Bell • Bank of Nova Scotia (NYSE:BNS) is estimated to report quarterly earnings at $1.78 per share on revenue of $8.09 billion.

Via Benzinga

Top 5 Health Care Stocks That May Dip ↗

January 27, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 05, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2023 ↗

February 17, 2023

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.